MPH Health Care AG is a listed investment company with a strategic focus on investments in the growth segments of the healthcare market around chronic diseases, medical aesthetic treatments and digitalisation in the healthcare sector. In addition, MPH specifically exploits potential in other high-growth and high-profit sectors. It invests for the long term and allows its shareholders to participate in the development of its holdings through an attractive dividend policy.

Stock

ISIN: DE000A289V03 | WKN: A289V0 | Stock exchange symbol: 93M1

Title name: Bearer Shares
Number of shares: 4,281,384
Designated Sponsor: ODDO SEYDLER BANK AG
First trading day: 01.09.2009

Share information

Downloads

You can find our current annual and interim reports here: Reports

| Investor News

MPH Health Care AG (ISIN: DE000A289V03) announces the preliminary IFRS consolidated results for the first half-year of 2025. Accordingly, equity decreased by 26% from EUR 277.9 million as of 31 December 2024 to EUR 205.1 million as of 30 June 2025. The net asset value (NAV) per share fell from EUR 64.90 (31 December 2024) to EUR 47.91 as of 30 June 2025.

| Investor News

  • Equity (net asset value) amounts to EUR 257.9 million, which corresponds to EUR 60.24 per share.
  • Equity ratio decreases slightly to 94.9% (31 December 2024: 95.5%)

| Investor News

  • Net profit (IFRS) increases to EUR 32.0 mn (previous year: EUR 29.5 mn)
  • EBIT increases by 9.1% to EUR 33.0 mn (previous year: EUR 30.2 mn)
  • Equity ratio: increase from 94.2% to 95.5%
  • Equity increases from EUR 251.0 mn to EUR 277.9 mn as of 31 December 2024

Contact

MPH Health Care AG
Grünauer Straße 5
12557 Berlin
Deutschland

T. +49 (0) 30 863 21 45 – 60

To the contact form